AKT reactivation induced by mTOR inhibition in tumor cells is likely to reduce its antitumor effects by activating pathways that attenuate its effects on proliferation and apoptosis; thus, it is an unexpected and potentially undesirable consequence of mTOR inhibition [19]. This evidence concerns the gene AKT1 and neoplasm.